IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
A Study of Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell Carcinoma
This study is currently recruiting participants.
Verified April 2016 by Nooshin Hashemi-Sadraei, University of Cincinnati
Sponsor:
Nooshin Hashemi-Sadraei
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Nooshin Hashemi-Sadraei, University of Cincinnati
ClinicalTrials.gov Identifier:
NCT02759575
First received: April 26, 2016
Last updated: April 29, 2016
Last verified: April 2016
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2018 |
| Estimated Primary Completion Date: | January 2018 (Final data collection date for primary outcome measure) |